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Protein-Induced glomerular hyperfiltration: Role of hormonal factors.
High protein diets acutely elevate the glomerular filtration rate. To
characterize this response we administered 1 g of protein/kg body
weight as a beef steak meal to nine, healthy male subjects and measured
glomerular filtration rate (inulin clearance), renal plasma flow (p-amino
hippurate clearance), plasma renin activity, aldosterone and plasma and
urinary catecholamines. The subjects ingested the meal on three
separate days and were pretreated with either placebo, 50 mg indometh-
acm (to inhibit renal prostaglandin synthesis), or 10 mg enalapril (to
inhibit angiotensin II synthesis). Following placebo treatment protein
feeding significantly increased the glomerular filtration rate, from a
pre-meal level of 101 7 ml/min/l 73 m2 to a post-meal level of 130
6 ml/min/l.73 m2, P C 0.005. A parallel rise in renal plasma flow and a
fall in renal vascular resistance were noted. Indomethacin pretreatment
attenuated the increase in glomerular filtration rate following the protein
meal, 105 6mllmin/l.73 m2 pre-meal level to 118 4 mI/min/l.73 m2
post-meal, P> 0.1. Enalapril pretreatment had no significant effect on
protein-induced glomerular hyperfiltration. Protein feeding following
placebo increased plasma aldosterone concenttation while the concen-
trations were unchanged in the studies where enalapril or indomethacin
was administered. Protein feeding following placebo or indomethacin
did not alter plasma renin activity while plasma renin activity rose
following enalapril administration. Urinary norepinephrine excretion
rose while plasma norepinephrmne concentration was unchanged in all
three study groups. A decrease in urinary dopamine excretion was also
noted four hours after the protein meal was ingested. The urinary POE2
excretion was unchanged following protein loading in the studies when
placebo was administered, while it fell by 50% in the studies when
indomethacin was administered. Plasma atrial natriuretie peptide con-
centrations were measured in six additional subjects following a protein
meal and the levels remained unchanged. Our data indicate that
protein-induced elevation of glomerular filtration rate may be mediated
by prostaglandins,
Ingestion of a protein meal acutely elevates the glomerular
filtration rate in humans [1—5]. Glomerular hyperfiltration in-
duced by high protein diet accelerates the progression of
chronic renal disease [6, 7]. Amelioration of this glomerular
hyperfiltration by dietary protein restriction reduces the pro-
gression of renal failure [8—11]. The mediators of this protein-
induced glomerular hyperfiltration are unknown. While prosta-
glandins, angiotensin II, catecholamines, vasopressin, and
atrial natriuretic peptides are well known regulators of renal
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blood flow and glomerular filtration rate [12, 13], their role in
mediating protein induced augmentation of glomerular filtration
has not been studied in man. The current studies were under-
taken to characterize the acute renal response to protein loading
and to define the role of various hormones in mediating this
response.
Methods
Nine, healthy male subjects 20 to 40 years old were studied at
the General Clinital Research Center (GCRC) of Temple Uni-
versity Hospital. The study protocol was approved by the
Research Review Committee, and informed consent was ob-
tained. A detailed history, physical examination and laboratory
evaluation were performed to exclude patients with cardiac,
renal and hepatic disorders, hypertension, diabetes mellitus,
alcoholism and obesity.
Each subject acted as his own control and was studied on
three occasions, each separated by one week. Four to five days
prior to entry the daily diet included 1 g/kg body weight of
protein, 150 mEq of sodium, and 60 mEq of potassium. To
verify that all subjects were in external sodium balance, a
24-hour urine sample was obtained prior to entry into the
GCRC. After an overnight fast, subjects voided at 7:00 a.m. and
ingested a water load of 20 mI/kg body weight. Subjects
remained supine except to void. An intravenous catheter was
inserted for blood drawing. Loading and sustaining infusions of
inulin and p-amino hippurate (PAH) in normal saline were
administered according to standard protocol [14]. Urine volume
was recorded hourly and replaced with water. Plasma and
urinary inulin and PAH were assayed at hourly intervals. At
10:00 a.m. subjects ingested placebo, 10 mg enalapril, or SO mg
indomethacin in a double-blind randomized fashion. At the
administered doses, enalapril and indomethacin have been
shown to inhibit the synthesis of angiotensin II and renal
prostaglandins, respectively 115—18]. At 12:00 noon, subjects
were served a cooked beef steak meal providing 1 g/kg body
weight of protein and the meal was consumed within thirty
minutes. This meal contained approximately 6 mEq of sodium
and 35 mEq of potassium. Following the protein meal, blood
and urine samples were collected for an additional four hours.
The plasma samples that were collected before treatment with
medication (prestudy), prior to the administration of protein
meal (pre-meal) and at two and four hours after the protein meal
were analyzed for plasma renin activity (PRA), plasma aldos-
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terone (PA), norepinephrine and epinephrine. Sodium and
potassium concentrations were measured in the hourly urine
samples. Dopamine and norepinephrine were measured in
pooled two-hour samples. All urine and plasma samples were
frozen and stored at —70°C until assayed. Pulse rate and blood
pressure were recorded at 30 minute intervals throughout the
entire study period.
To study the effect of protein loading on urinary prostaglan-
din (PG) excretion, seven additional subjects, including three
females, received a standard protein load following pretreat-
ment with either placebo or 50 mg of indomethacin orally in a
double-blind randomized fashion as described above. To avoid
the effect of high urine flow rates on urinary PG excretion, these
subjects received no water load initially [191. The urine samples
were collected at two hour intervals.
In six additi5nal subjects an identical protocol was followed
and a protein meal was administered as described above. At
intervals of two hours plasma samples were obtained for
measurement of atrial natriuretic peptide (ANP). These sub-
jects received no pretreatment medication.
Plasma and urine sodium and potassium concentrations were
measured on a flame photometer (Instrumentation Laboratory,
Lexington, Massachusetts, USA). PRA was measured by ra-
dioimmunoassay and expressed as ng/ml/hr of generated angi-
otensin I [20]. PA was measured using an '251-aldosterone assay
kit (Diagnostic Products, Los Angeles, California, USA) [21].
Plasma epinephrine and norepinephrine were measured by
radioenzymatic assay [22, 23]. Urinary dopamine and norepi-
nephrine were extracted using a combination of ion exchange
and alumina chromatography [24]. These amines were sepa-
rated by liquid chromatography and quantitated by electro-
chemical detection [25]. Inulin and PAH were measured using
standard chemical analysis [14]. Plasma ANP samples were
analyzed by radioimmunoassay at the laboratories of Dr. John
Burnett, Jr. at the Mayo Clinic, Rochester, Minnesota [26].
Urinary PGE2 was determined by radioimmunoassay [27].
Urine samples (2 ml) were acidified to pH 2.9 to 3.1 with formic
acid and run through a prewashed octadecyl (C18) silica column.
The column was eluted successively with water (20 ml), etha-
nollwater (85:15 vollvol, 20 ml), petroleum ether (20 ml) and
methyl formate (10 ml). The methyl formate fraction containing
the prostanoids was evaporated to dryness under a stream of
nitrogen. The dry residue was reconstituted in toluene/ethyl
acetate/methanol (60:40:1, volivol) and run through a silica
column that had been prewashed and equilibrated with toluene/
ethyl acetate/methanol/formic acid (60:40:20:1, vol/vol) and
toluene/ethyl acetate (60:40, vol/vol), respectively. The column
was eluted first with 10 ml of toluene/ethyl acetate (60:40,
vollvol) and then with 12 ml of toluene/ethyl acetate/methanoll
formic acid (60:40:5:1, vol/vol); the latter fraction, containing
the prostanoids, was dried under a stream of nitrogen and was
reconstituted with radioimmunoassay buffer. PGE2 was mea-
sured by radioimmunoassay on unextracted KHB. The anti-
body to PGE2 was purchased from Sigma Chemical Co. (St.
Louis, Missouri, USA). The PGE2 recovery ranged to 72 to
88%. Samples were run in triplicate and final data corrected for
recovery. The sensitivity of the assay was 25 pg/mI.
Inulin and PAH clearances are expressed as mI/mm/i .73 m2.
Renal blood flow is calculated in a standard fashion from the
hematocrit and PAH clearance. Renal vascular resistance is
Table 1. Urinary sodium excretion (UNaV), potassium excretion
(UKV) and creatinine clearance (Ccr) values prior to entry into the
three treatment protocols
Placebo Enalapril Indomethacin
UNaV mEq/day 138 10 135 15 145 18
UKV mEqlday 47 6 57 7 62 7
Ccr mi/mm 134 7 123 5 134 6
calculated from the mean arterial pressure and renal blood flow
and is expressed as dynes . sec cm5 [28]. All data are ex-
pressed as mean SEM. The response to protein meal in each
treatment group was analyzed by two way analysis of variance
with period and subject effects [29]. The values obtained in each
study period were further compared to pretreatment and pre-
meal periods by paired t-tests. In comparing the post-meal
response between the three treatment groups, mean value of the
second, third and fourth hours after the meal was used. This
was done to allow adequate time for the meal to take full effect.
The Wilcoxon rank sum test and the paired t-test were used to
compare the means of the responses noted prestudy, pre-meal
and the post-meal periods among the three treatment groups
[30], and only the larger of the two P values obtained is
reported. A P value less than 0.05 was considered significant.
Results
Renal response to protein loading
Daily urinary sodium and potassium excretion and creatinine
clearance were similar prior to entry into the three treatment
protocols (Table 1). In the placebo treated group inulin clear-
ance (C1) increased rapidly in response to protein loading (Fig.
1). The values for C1 were identical in the prestudy (100 7
ml/min/1.73 rn2) and the pre-meal (101 7 mllmin/1.73 m2)
period. The levels noted during the second (P < 0.05), third (P
<0.01) and fourth (P < 0.01) hours after protein loading were
all significantly higher than the pre-meal values. Although there
was substantial individual variation, the highest values for C1
occurred between the second and fourth hours after protein
loading. The increase in CPAH and the decrease in renal vascular
resistance paralleled the increase in C1 (Fig. 1). Enalapril and
indomethacin did not alter the basal levels of C1. Indomethacin
pretreatment, however, significantly blunted the increment in
GFR caused by the meal (Fig. 2). The mean value for C1
following protein loading in the placebo treated studies (130
6 mI/mm/i .73 m2) was significantly higher than the mean value
noted in the indomethacin treated studies (118 4 ml/min/l .73
m2, P < 0.05). The post-meal GFR reached a value of 120
ml/min/l .73 m2 or greater in seven of nine placebo studies but
only in two of the indomethacin studies (Fig. 2). Enalapril
pretreatment did not significantly alter the protein-induced
glomerular hyperfiltration (Fig. 3). The increase in CPAH and the
fall in renal vascular resistance in response to protein loading
however were similar in all three treatment protocols (Fig. 3).
Urinary sodium and potassium excretion increased significantly
in response to protein loading in all three study groups (Table
2). Although the sodium excretion rates were generally higher
in the enalapril treated studies and lower in the indomethacin
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Fig. 1. Changes in C5,,, CPAJJ and renal vascular resistance following a
protein load in subjects pretreated with placebo. The shaded area (E)
represents the time period during which protein meal was administered.
(*) P < 0.05 and (**) P C 0.01 compared to values noted at 0 hour. The
data were analyzed by analysis of variance. Data from each time period
were further compared to yalues at 0 hour by paired t-test.
treated studies, the differences between the groups did not
reach statistical significance.
Hormonal response to protein loading
Plasma aldosterone concentrations increased while PRA,
plasma epinephrine and norepinephrine were unchanged in
response to protein loading in the placebo treated studies (Table
3). Inhibition of angiotensin II synthesis with enalapril signifi-
cantly increased PRA which was sustained through the study
period. PRA was unchanged in the indomethacin trçated studies
(Table 3). PA concentrations increased significantly in the
placebo studies, presumably in response to potassium con-
tained in the protein meal. In the enalapril and indomethacin
studies PA concentrations were unchanged from pre-meal lev-
els. Plasma epinephrine and norepinephrine concentrations
were unchanged by protein administration and the levels noted
were similar in the three treatment groups. A significant in-
crease in the urinary norepinephrine excretion was noted two
hours after protein loading and the values returned to pre-meal
levels four hours after the meal. The dopamine excretion rates
noted four hours after the protein meal were significantly less
than those noted two hours after the meal (P C 0.05). Paradox-
ically, excretion rates for dopamine, actually fell when maximal
increases in C1,, were noted.
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Fig. 2. Inulin clearance values in 9 subjects pretrea ted with placebo
() or indomethacin (Efi) following protein meal. The pre-meal values
for each subject are shown in parentheses. () P C 0.05 when the
placebo studies are compared to indomethacin studies.
In the sevep subjects receiving the protein meal following
placebo administration urinary PGE2 excretion rates were un-
changed (Fig. 4). Following indomethacin administration excrè-
tion rates for PGE2 fell significantly from a prestudy level of
2548 474 pg/mm to 1233 167 pg/mm in the pre-meal period
(P C 0.02), 1109 209 pg/mm two hours after the meal (P C
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Fig. 3. Changes in C1,,, CPAI-, and renal vascular resistance following
protein loading in placebo, enalapril and indomethacin treated studies.
Pre refers to measurements obtained before protein meal, post refers to
the mean value of hours 2, 3 and 4 after the protein meal. The data are
compared by paired t-test.
Pre Post Pre Post Pre Post
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Table 2. Effect of protein loading on un ne volume (V), urinary sodium excretion (UNaV), potassium excretion (UKV) in 9 subjects
Prestudy
— 2 hrs
Pre-meal
0 hr
Post-meal
1 hr 2 hrs 3 hrs 4 hrs
P 9.9 0.9 13.7 14.0 1.0 15.9 l.0 19.2 l.6a 19.2 1.4
V mi/mm E
I
p
11.7 1.0
10.3 0.9
165 22
13.9 1,1
10.9 1.0
216 28
13.1 1.4
10.0 1.0
223 32
19.0 1.0
12.3 1.8
266 33
19.6 l.I
15.2 l.4a
273 37
21.2 l.416.3 14
239 35
UNaV mEq/min EI
P
180 15
149 19
69 10
223 17
140 16
77 8
279 22
141 30
77 7
325 l9
143 15
87 10
351 30
199 15"
131 l5
310 26
184 13
118 14
UKV mEqimin EI
72 6
63±7
74 9
77±8
72 11
76±9
97 8
78±8
142 12"
136±13a
118 9"
116±10"
Abbreviations are: P, placebo; E, enalapril; 1, indomethacin.
Significant (P < 0.05) increase from pre-meal values
Table 3. Effect of protein loading on plasma renin activity (PRA),
plasma aldosterone (PA), norepinephrine (PNe), epinephrine (PEPj),
and urinary excretion of norepinephrine (UNaV) and dopamine
(UDaV) in 9 subjects
Post-meal
Prestudy Pre-meal
—2 hrs 0 hr 2 hrs 4 hrs
PRA P 2.1 0.5 2.6 0.5 3.2 0.7 2.8 0.6
ng/ml hr E 2.9 0.6 4.1 1.0 6.0 1.2" 47 o.7
I 2.0 0.4 1.8 0.2 2.0 0.4 2.3 0.7
Pa P 9.3 2.4 7.4 1.3 13.6 1.sa 7.1 1.1
ng/di E 6.0 0.5 6.9 1.3 5.8 1.6 4.0 0.5
I 10.2 1.8 9,7 1.9 10.8 2.0 4.8 0.8
PNa P 180 37 176 25 195 21 161 25
pg/mi E 183 46 191 21 191 24 246 35
I 148 12 174 16 180 24 194 17
PEj P 22±5 36±6 26±6 28±3
pg/mi E 26±6 32±5 27±7 42±8I 25±3 30±5 26±4 32±7
UNV P 29±4 28±3 39±5" 29±6
ng/min E 31 6 31 3 44 6 36 5I 28±4 28±3 38±6a 33±5
UaV P 217 26 189 26 219 17 147 15b
ng/min E 201 25 203 23 219 24 151
I 216 30 198 25 226 19 173 30l
0.02) and 1383 182 pg/mm four hours after the meal (P <
0.05). This fall in PGE2 excretion was consistently observed in
all subjects, including three females participating in the study.
In addition the values noted in the indomethacin studies were
significantly less during the pre-meal and two and four hours
post-meal compared to the corresponding values noted in the
placebo studies (P <0.05).
Atrial natriuretic peptide concentrations were measured in
six subjects who received no treatment prior to protein inges-
tion. The plasma ANP levels obtained in the prestudy (29 2
pg/mi), pre-meal (29 3 pg/ml), two hours (29 2 pg/mI), and
four hours post-meal (26 1 pg/mI) were all similar.
Discussion
Our studies confirm that a protein meal acutely increases
glomerular filtration rate (GFR) and renal plasma flow (RPF) for
two to three hours. Renal vascular resistance is significantly
reduced during the same period. While individual variation is
substantial, the peak response in all subjects occurred 1.5 to 2.5
hours after protein ingestion. In contrast to our observation that
GFR and RPF manifest a prolonged increase, Bosch et al could
only demonstrate a significant rise 2.5 hours after the meal [1].
Values at earlier and later periods were not different. Hostetter
administered either beef steak or an amount of sodium equiva-
lent to that contained in the steak, to healthy volunteers on
separate days. The hourly GFR values for three hours after the
steak meal, although significantly higher than those noted
following the salt solution, were not significantly higher than
basal, pre-meal values [4]. Rodriguez-Iturbe, Herrera and
Garcia reported a 50% increase in creatinine clearance, calcu-
lated from a two-hour urine collection following a protein meal
[3]. It should be noted that the acute protein load administered
by Rodriguez-Iturbe et al was much larger. None of these
studies report sodium balance prior to acute protein loading.
The discrepancy in the response to a protein meal in these
studies could indeed be explained by possible differences in
sodium balance, prior protein intake and the amount of protein
administered as an acute load. We controlled for all of these
variables in our studies and noticed that protein induced hyper-
filtration was sustained for two to three hours in subjects
ingesting a normal sodium diet. It is interesting to note that
Ruilope et al found no increase in GFR in response to an amino
Placebo or
indomethacin Protein loadingn. +400
WE
-400
-800'
—1200
—1600
Time, hours
Prestudy Pre-meal Post-meal
Fig. 4. Changes in urinaly prostagiandin (PGE2) excretion rates in
response to protein loading following pretreatment with placebo or 50
mg indomethacin in 7 subjects. (*) P < 0.05 when placebo studies are
compared to indomethacin studies.
—2 0 2 4
Abbreviations are: P, placebo; E, enalapril; I, indomethacin.
a Significant (P < 0.05) increase from prestudy valuesb Significant (P < 0.05) decrease from values notes two hours after
protein loading
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acid infusion in subjects ingesting a 20 mEq sodium diet [31].
Elevations in circulating levels of vasopressor hormones, such
as angiotensin II and norepinephrine, in response to sodium
depletion might have prevented the expected increase in GFR
and RPF following protein ingestion.
Our studies indicate that prostaglandins may play a key role
in mediating protein-induced increases in GFR. Administration
of 50 mg of indomethacin resulted in a 50% decrease in urinary
PGE2 excretion and significantly attenuated the hyperfiltration
in response to a protein meal. A direct effect of indomethacin on
GFR or an indirect effect through hormonal systems other than
prostaglandins cannot be excluded by these studies. The in-
crease in GFR induced by the infusion of amino acids or
arginine is also attenuated by pretreatment with inhibitors of
prostaglandin synthesis [31, 32]. Levine et al blocked the effect
of protein on GFR in rats by pretreating with aspirin or
meclofenamate [33]. It is unknown whether prostaglandins play
an active or a permissive role in mediating protein induced
hyperfiltration. We found no significant change in urinary PGE2
excretion rates following protein meal in the placebo studies.
Hostetter also found no increase in urinary PGE excretion in
humans following a protein meal [4]. These studies together
suggest that renal prostaglandins play a permissive rather than
active mediator role in protein induced hyperfiltration. Further
studies are needed to critically evaluate the role of PGF1a and
thromboxane in mediating protein induced hyperfiltration.
It is of interest to note that in our studies indomethacin, while
blocking the effect of protein on GFR, did not alter the increase
in RPF or the fall in renal vascular resistance (Fig. 2). This
dissociation of GFR and RPF in the presence of indomethacin
suggests that the prostaglandin synthesis inhibitor exerts its
effect by altering glomerular surface area, permeability or by
offsetting the balance between afferent and efferent renal vas-
cular resistances. Nath, Chmielewski and Hostetter [34] re-
cently demonstrated that acute administration of indomethacin
to subtotally nephrectomized rats results in a fall in glomerular
ultrafiltration coefficient (Kf). At the doses employed indometh-
acm might have left the vascular PG synthesis intact thus
allowing the vasodilatory response to protein meal to manifest.
Our data from human studies do not allow further delineation of
the mechanism(s) of action of prostaglandin synthesis inhibitors
on protein induced hyperfiltration.
Inhibition of angiotensin II synthesis with enalapril failed to
alter protein induced increases in GFR. The increase in PRA
and the relative suppression of PA confirm that adequate
angiotensin II inhibition had been achieved. It remains to be
shown whether higher doses of enalapril will attenuate the GFR
response to protein.
The absence of changes in plasma and urinary catecholamine
levels make it unlikely that these hormones mediate protein
induced hyperfiltration. Williams et al reported an increase in
urinary dopamine excretion when protein was administered as a
tuna fish meal [35]. We are unable to confirm this observation,
although we administered protein as beef steak. Indeed we
noted a fall in urinary dopamine excretion when maximal
increases in GFR were noted. In the absence of controlled
studies (without an acute protein meal) we do not know if the
fall in dopamine excretion is related to circadian variation in its
excretion or whether it is related to the ingestion of the protein.
Inhibition of dopamine synthesis by carbidopa did not alter the
increases in creatinine clearance following protein loading [35].
Taken together these observations suggest that dopamine does
not mediate protein induced hyperfiltration.
Since protein ingestion acutely increased GFR, RPF and
urinary sodium excretion, it followed logically that ANP might
mediate these responses. The absence of changes in plasma
ANP levels suggests that ANP is unlikely to mediate protein
induced hyperfiltration. Finally, Chan et al in a recent prelimi-
nary communication reported increases in plasma vasopressin
concentration following protein meal and suggested that this
hormone may potentially mediate the GFR response to a
protein meal [36]. Under the conditions of our study water
loaded subjects underwent maximal free-water diuresis (Uosm
< 80 mOsm/kg), thereby making it unlikely that vasopressin
played any significant role in augmenting glomerular filtration.
In summary, administration of a standard, beef steak protein
load to healthy subjects ingesting 150 mEq of sodium daily
caused an increase in GFR, RPF and a fall in renal vascular
resistance that was sustained for two to three hours. Inhibition
of angiotensin II synthesis with enalapril did not significantly
alter this response to a protein meal. Inhibition of prostaglandin
synthesis with indomethacin attenuated the increase in GFR
without altering the changes in renal plasma flow and renal
vascular resistance. Plasma and urinary catecholamine levels
and plasma ANP levels were unchanged following the protein
meal. We conclude that prostaglandins in part mediate the
glomerular hyperfiltration resulting from protein ingestion.
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